Literature DB >> 7048901

Clinical and pathophysiologic aspects of aminoglycoside nephrotoxicity.

H D Humes, J M Weinberg, T C Knauss.   

Abstract

Aminoglycoside antibiotics continue to be a mainstay of therapy in the clinical management of gram negative infections, but a major factor in the clinical use of aminoglycosides is their nephrotoxicity. With gram negative organisms accounting for the majority of hospital acquired infections, the occurrence of aminoglycoside induced acute renal failure has become commonplace. Presently at least 10% of all cases of acute renal failure can be attributed to these antibiotics. This article will cover the renal handling of the aminoglycosides, the pathogenetic mechanisms of nephrotoxicity, and the clinical aspects of aminoglycoside induced acute renal failure with particular emphasis on recent data which have increased our understanding of the interaction of aminoglycosides with the renal tubular cell and the effects of this interaction on cellular function and integrity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7048901     DOI: 10.1016/s0272-6386(82)80039-5

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  12 in total

1.  Influence of intraperitoneal gentamicin on peritoneal transport in IPD patients.

Authors:  L Janicka; M Majdan; J Solski; E Baranowska-Daca; E Kimak
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

Review 2.  Aminoglycosides: An Overview.

Authors:  Kevin M Krause; Alisa W Serio; Timothy R Kane; Lynn E Connolly
Journal:  Cold Spring Harb Perspect Med       Date:  2016-06-01       Impact factor: 6.915

3.  Genome-Scale Model-Based Identification of Metabolite Indicators for Early Detection of Kidney Toxicity.

Authors:  Venkat R Pannala; Kalyan C Vinnakota; Shanea K Estes; Irina Trenary; Tracy P OˈBrien; Richard L Printz; Jason A Papin; Jaques Reifman; Tatsuya Oyama; Masakazu Shiota; Jamey D Young; Anders Wallqvist
Journal:  Toxicol Sci       Date:  2020-02-01       Impact factor: 4.849

4.  Streptomycin toxicity in primary cultures of flounder renal proximal tubule cells.

Authors:  K G Dickman; J L Renfro
Journal:  In Vitro Cell Dev Biol       Date:  1990-06

Review 5.  Potassium and anaesthesia.

Authors:  J E Tetzlaff; J F O'Hara; M T Walsh
Journal:  Can J Anaesth       Date:  1993-03       Impact factor: 5.063

6.  Increased renal DNA synthesis in vivo after administration of low doses of gentamicin to rats.

Authors:  G Laurent; P Maldague; M B Carlier; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

7.  Neomycin inhibits mastoparan-induced lactate dehydrogenase release, ethidium bromide accumulation, and intracellular fluorescein depletion in MDCK cells.

Authors:  S P Eng; C S Lo
Journal:  Cell Biol Toxicol       Date:  1990-01       Impact factor: 6.691

8.  Calcium is a competitive inhibitor of gentamicin-renal membrane binding interactions and dietary calcium supplementation protects against gentamicin nephrotoxicity.

Authors:  H D Humes; M Sastrasinh; J M Weinberg
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

9.  Protection by antibiotics against myeloperoxidase-dependent cytotoxicity to lung epithelial cells in vitro.

Authors:  A Cantin; D E Woods
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

10.  Serial trough and peak amikacin levels in plasma as predictors of nephrotoxicity.

Authors:  A M Contreras; G Gamba; J Cortés; Y Santiago; F Nares; G Jimenez-Sanchez; J Bobadilla; G López; A Valadez; A Espinosa
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.